AB
Assembly Biosciences Inc
🇺🇸XNAS.ASMBUnited StatesHealthcare
$27.08USDdown -1.88 (-6.49%)OpenEnd of day4:15 PM
Price$27.08-1.88 (-6.49%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0453962070
- CUSIP
- 045396108
Company
- Employees
- 73
- Headquarters
- South San Francisco, United States
- Website
- https://www.assemblybio.com
- CEO
- Mr. Jason A. Okazaki J.D.
Market
- Shares outstanding
- 20.4M
- Market cap
- $551.36M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $551.36M
- EPS LTM
- -$0.00calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $74.84M+125.12%up year on year
- Net income
- -$42K+99.89%up year on year
- Gross margin
- 77.73%+201.25%up year on year
- Free cash flow
- -$38.57M+30.94%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.